Adaptive Biotechnologies

ADPT · NASDAQ🇺🇸

Overview

Earnings Dividends Seasonality Metrics

Reports earnings in 11 days

after market closes

Total Revenue

$71.7M

Previous year: $47.5M

+51.0%

EPS

-$0.09

Previous year: -$0.23

-60.9%

clonoSEQ Tests Delivered

30.04K

Adjusted EBITDA

$4.14M

Previous year: -$16.4M

Previous year: $47.9M

Loading...

Adaptive Biotechnologies

Unlock previous datapoints

Upgrade

Adaptive Biotechnologies

Unlock previous datapoints

Upgrade

Adaptive Biotechnologies Revenue by Segment

Revenue by Segment

MRD Business Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

Immune Medicine Business Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$2.23B

P/E Ratio

-21.03

Sector

N/A

Industry

N/A

52-Week High

$20.4

52-Week Low

$6.81

clonoSEQ Tests Delivered

30.04K

Adjusted EBITDA

$4.14M

MRD Revenue Growth

54%

clonoSEQ Test Volume Growth

43%

MRD Pharma Regulatory Milestone Revenue

$19.5M

Products

Get in Touch

Resources

Adaptive Biotechnologies

Adaptive Biotechnologies

Adaptive Biotechnologies

Adaptive Biotechnologies Revenue by Segment

Revenue by Segment

MRD Business Revenue

Immune Medicine Business Revenue

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics